COX univariable and multivariable analyses identified the following as independent factors influencing overall survival after brain metastasis (OS-BM): the HER2-positive molecular subtype of breast cancer (protective factor), brain metastasis as the first site of metastasis (protective factor), and leptomeningeal metastasis (risk factor) (Table 4). This evidence concerns the gene ERBB2 and breast carcinoma.